Biotech Values

[DewDiligence]

1Q24 worldwide Botox sales=$1.381B, -7% QoQ*, flat YoY

https://news.abbvie.com/2024-04-26-AbbVie-Reports-First-Quarter-2024-Financial-Results

• US therapeutic: $611M (-6% QoQ, +4% YoY)
• US cosmetic: $389M (-14% QoQ*, -5% YoY)
--
US total: $1.00B (61% therapeutic; 39% cosmetic) was 72% of worldwide total


• Ex-US therapeutic: $137M (+8% QoQ, +5% YoY)
• Ex-US cosmetic: $244M (-8% QoQ*, -3% YoY)
--
Ex-US total: $381M (36% therapeutic; 64% cosmetic) was 28z% of worldwide total.


*Botulinum-toxin sales for cosmetic indications are seasonally stronger during the second and fourth calendar quarters than the first and third calendar quarters.